Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.

The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.



Meeting/Conference: Next Gen Immuno-Oncology Congress - 14 - 15 March 2017



London - UK


Next Gen Immuno-Oncology Congress to be held on 14th and 15th March 2017  in London UK aims to bring academicians, researchers and scientist from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the growth of existing therapeutics and pave way for emerging next generation therapeutics. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.


Contact Information:

Contact Person – Ajay Nimbalkar


Posted: 2016-07-07 More...

Journal Announcement: New Impact Factor of 1.829 for Current Oncology!


We are pleased to announce to our readers that Current Oncology’s 2015 Impact Factor has increased to 1.829! This is an increase from our 2014 stats, where we received an impact factor of 1.785.

The journal impact factor is a measure of citation frequency that reflects the average number of citations to articles published in science and social science journals. Impact factors are calculated annually for those journals that are indexed in Thomson Reuters Journal Citation Reports. The impact factor of a journal in a given year is the average number of citations a paper published in that journal received during the two previous years. The impact factor is often used to rank the relative importance and scientific caliber of a journal within its field.

Our 2015 Impact Factor is a significant achievement for the journal, and demonstrates the increased recognition of Current Oncology in the field, and the improved relevance and quality of our articles. Thank you to our team of Editors and Section Editors, Reviewers and Authors for their valuable contribution to the journal. We look forward to continued success in 2016 as the journal continues to strengthen and grow!

Multimed Inc.
Publisher of Current Oncology

Posted: 2016-06-16 More...

Meeting/Conference: Atlantic Canada Oncology Group Annual CME, Halifax, June 18-19, 2016


ACOG will host our 20th annual education event in Halifax on Friday afternoon and Saturday morning, June 18-19. Registration includes a lobster dinner and social event on the waterfront Friday evening.

The meeting will focus on breast cancer and a variety of other topics. Details of the program and registration are posted at, or email

Posted: 2016-04-04
More Announcements...

Vol 23, No 4 (2016)

Table of Contents



Original Article(s)

Cancer Control and Prevention

K.M. Decker, E.V. Kliewer, A.A. Demers, K. Fradette, N. Biswanger, G. Musto, B. Elias, D. Turner
L. Provencher, J.C. Hogue, C. Desbiens, B. Poirier, E. Poirier, D. Boudreau, M. Joyal, C. Diorio, N. Duchesne, J. Chiquette

Cancer Rehabilitation and Survivorship

A.A. Kirkham, S.E. Neil-Sztramko, J. Morgan, S. Hodson, S. Weller, T. McRae, K.L. Campbell

Medical Oncology

A.L. Mahar, N.G. Coburn, D.J. Kagedan, R. Viola, A.P. Johnson
H. Sibai, J.T. Seki, T.Q. Wang, N. Sakurai, E.G. Atenafu, K.W.L. Yee, A.C. Schuh, V. Gupta, M.D. Minden, A.D. Schimmer, J.M. Brandwein

Palliative Care

M.E. Giuliani, R.A. Milne, M. Puts, L.R. Sampson, J.Y.Y. Kwan, L.W. Le, S.M.H. Alibhai, D. Howell, N. Abdelmutti, G. Liu, J. Papadakos, P. Catton, J. Jones

Surgical Oncology

D.J. Kagedan, F. Frankul, A. El-Sedfy, C. McGregor, M. Elmi, B. Zagorski, M.E. Dixon, A.L. Mahar, J. Vasilevska-Ristovska, L. Helyer, C. Rowsell, C.J. Swallow, C.H. Law, N.G. Coburn

Review Article(s)

M.N. Khan, A.M. Sharma, M. Pitz, S.K. Loewen, H. Quon, A. Poulin, M. Essig
F. Rahman, S.J. Seung, S.Y. Cheng, H. Saherawala, C.C. Earle, N. Mittmann

Practice Guideline(s)

M.K. Krzyzanowska, C. Walker-Dilks, C. Atzema, A. Morris, R. Gupta, R. Halligan, T. Kouroukis, K. McCann
C.T. Kouroukis, N.P. Varela, C. Bredeson, J. Kuruvilla, A. Xenocostas

Case Report(s)